Insulin infusion therapy for myocardial infarction

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Research

Background:

• Recent decade shows increased interest in insulin administration for myocardial infarction (MI) management.
• Review focuses on clinical trials of insulin infusion therapy during the reperfusion therapy era.
• Discusses implications of the HI-5 (Hyperglycaemia: Intensive Insulin Infusion In Infarction) study.

Purpose of the Study:

• To review clinical trials of insulin infusion for myocardial infarction.
• To evaluate the impact of insulin-focused versus glycemic-control-focused protocols.
• To discuss the findings of the HI-5 study in the context of existing evidence.

Main Methods:

• Systematic review of clinical trials investigating insulin therapy in myocardial infarction.
• Categorization of trials into 'insulin focus' and 'glycaemia focus' protocols.
• Analysis of study outcomes in relation to therapeutic approach.

Main Results:

• Insulin-focused protocols did not demonstrate improvement in myocardial infarction outcomes.
• Trials with a primary aim of tight glycemic control yielded inconclusive results.
• The HI-5 study findings are considered within the broader evidence base.

Conclusions:

• Current evidence does not support insulin-focused insulin infusion for improving MI outcomes.
• The role of intensive glycemic control in MI management remains uncertain.
• Further research is needed to clarify the potential benefits of glycemic control in MI patients.